Evidence map›Paper›PMID 35844805›Full record

ArticleInternational journal of biological sciences2022

CCDC65, a Gene Knockout that leads to Early Death of Mice, acts as a potentially Novel Tumor Suppressor in Lung Adenocarcinoma.

Ziyan Zhang, Ping Xu, Zhe Hu, Zhaojian Fu, Tongyuan Deng, Xiaojie Deng, Lanzhu Peng, Yingying Xie, Lingzhi Long, Dayong Zheng and 10 more

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Role of ENO1 and its targeted therapy in tumors.Journal of translational medicine · 2024
    Review
  10. Article
  11. Article
  12. Advances of E3 ligases in lung cancer.Biochemistry and biophysics reports · 2024
    Review
  13. Ropivacaine suppresses the progression of renal cell carcinoma through regulating the lncRNA RMRP/EZH2/CCDC65 axis.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 1 country.

Ziyan ZhangCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Ping XuCancer Research Institute, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Zhe HuCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Zhaojian FuDepartment of Oncology, Dali Bai Autonomous Prefecture People's Hospital, Dali, Yunnan, 671000, China.
Tongyuan DengCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Xiaojie DengCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Lanzhu PengCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Yingying XieCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Lingzhi LongDepartment of Pulmonary and Critical Care Medicine, The Third Xiangya Hospital of Central South University, Changsha, 410000, China.
Dayong ZhengCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Peng ShenDepartment of Oncology, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, China.
Mengmin ZhangCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Bin GongCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Zhibo ZhuCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Junhao LinCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Rui ChenDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Zhen LiuCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
Huilin YangCancer Research Institute, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Rong LiCancer Research Institute, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Weiyi FangCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315 Guangzhou, China.
TCM-Intigrated Cancer Center of Southern Medical University · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNGuangdong Medical College · CNGuangzhou Medical University · CNNanfang Hospital · CNPeking University Shenzhen Hospital · CNSouthern Medical University · CNThird Xiangya Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CCDC65 is a member of the coiled-coil domain-containing protein family and was only reported in gastric cancer by our group. We first observed that it is downregulated in lung adenocarcinoma based on the TCGA database. Reduced CCDC65 protein was shown as an unfavorable factor promoting the clinical progression in lung adenocarcinoma. Subsequently, CCDC65

Indexed as

Adenocarcinoma of LungGlycoproteinsLung NeoplasmsAnimalsCell Line, TumorCell ProliferationCytoskeletal ProteinsF-Box-WD Repeat-Containing Protein 7Gene Knockout TechniquesMiceMice, KnockoutUbiquitin-Protein LigasesCcdc65 protein, mouseCytoskeletal ProteinsF-Box-WD Repeat-Containing Protein 7GlycoproteinsUbiquitin-Protein LigasesCCDC65Cell cyclec-MycENO1Knockdown miceUbiquitin degradation

Identifiers

PMID35844805
PMCPMC9274497
OpenAlexW4285117543

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.